Identification of host factors required by the tick-borne Powassan virus
Identification of host factors required by the tick-borne Powassan virus
批准号:
10307148
负责人:
Charles M Rice
金额:
$21.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-11-23 至 2023-10-31
关键词:
Antiviral AgentsArbovirusesBiologyBiteCRISPR screenCandidate Disease GeneCell LineCellsCenters for Disease Control and Prevention (U.S.)ClinicalClustered Regularly Interspaced Short Palindromic RepeatsConfusionDevelopmentDiseaseDrug TargetingDrug resistanceEcosystemEncephalitisFDA approvedFeverFlaviviridaeFlavivirusFlavivirus InfectionsFutureGenesGeneticGenomic LibraryGeographyGoalsHeadacheHealthHemiplegiaHemorrhageHumanHuman GenomeImpairmentInfectionInfection ControlIntegration Host FactorsInterventionInvertebratesIxodesKnock-outMeasuresMemoryMemory LossMorbidity - disease rateMotor Skills DisordersMuscular AtrophyMutationNatural ImmunityNeurologic SymptomsPatientsPersonsPolymerasePowassan virusProteinsReadinessReportingRibavirinRoleSeizuresSeroprevalencesSupportive careSymptomsTechnologyTherapeuticTherapeutic InterventionTicksViral Hemorrhagic FeversVirusVirus DiseasesVirus ReplicationVomitingWorkZIKAacaricideadaptive immunityarthropod-borneclinical phenotypedesigndrug developmentgenome-wideinfection riskinsightinvertebrate hostmembermortalitymosquito-bornepreventprophylactictick-bornetick-borne flavivirustissue tropismvector tickwarm temperature
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Flaviviruses cause significant morbidity and mortality worldwide. The sudden emergence and spread of viruses
such as Zika illustrate our vulnerability and emphasize the need for preparedness against related emerging
viruses. In addition to mosquito-borne flaviviruses, members of tick-borne flaviviruses pose an increasing global
threat for which we lack effective antivirals.
Powassan virus (POWV) is an emerging virus transmitted by the bite of infected Ixodes ticks. The
seroprevalence of POWV in humans is mostly unknown as infections may often be asymptomatic. However,
symptomatic POWV infections may progress in to severe and sometimes fatal encephalic disease with mortality
rates of ~10% and surviving patients often suffer from debilitating long-term neurologic symptoms. The severe
clinical consequences of infections with POWV and other tick-borne flaviviruses and the lack of specific
treatments highlight an urgent need for a better understanding of these viruses in their tick and mammalian hosts
so that preventative and therapeutic treatments can be developed.
The goal of this project is to identify host factors required by POWV that may also impact a wide range
of existing and emerging flaviviruses. These host proteins may represent suitable targets for antiviral
interventions, and we hypothesize that impaired virus replication due to their inhibition may allow innate and
adaptive immunity to control the infection. Further, we propose to compare a panel of flaviviruses, including
POWV, and their requirements for the identified host factors in both vertebrate and invertebrate cells. We believe
these approaches will allow us to prioritize candidate genes for future drug development studies.
The proposed studies will utilize CRISPR/Cas9 screening technology to knock out every gene in the
human genome with the goal of identifying host factors that facilitate POWV infection. We will use a similar
approach in a targeted, arrayed format to evaluate the identified host factors in various human and tick cell lines
during infection with diverse flaviviruses.
We expect that this work will broaden our understanding of tick- and mosquito-borne flaviviruses,
specifically in terms of clinical phenotype (encephalitic vs hemorrhagic disease) and the shared need for host
factors. In addition, it will help to define which genes govern host species and tissue tropism. Together, this work
will provide a wealth of new insights into many aspects of flavivirus biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Employing viruses to unravel the functional significance of the m5C epitranscriptome
-
批准号:10638533
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
-
批准号:10667182
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10446423
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10553697
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10570297
-
项目类别:
-
资助金额:$61.93万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10327991
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10841239
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10446620
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Virology Core
-
批准号:10513915
-
项目类别:
-
资助金额:$528.97万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
-
批准号:10587597
-
项目类别:
-
资助金额:$46.09万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
-
批准号:10707260
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10576892
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10360541
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10211567
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Defining therapeutic drug targets for SARS-CoV-2-specific and pan-coronavirus inhibition
-
批准号:10238377
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
-
批准号:10555333
-
项目类别:
-
资助金额:$61.11万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
Identification of host factors required by the tick-borne Powassan virus
-
批准号:10154884
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
In search of an HBV cure: novel model systems and targets
-
批准号:10400212
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
HEP DART 2019: Frontiers in Drug Development for Hepatology
-
批准号:9914390
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
In search of an HBV cure: novel model systems and targets
-
批准号:10633080
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
海外基金